摘要
GENEVA,June 1(Xinhua)–The World Health Organization(WHO),on June 1,validated the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use.At the WHO press conference,Director-General Tedros Adhanom Ghebreyesus announced that the Sinovac-CoronaVac vaccine has been given WHO Emergency Use Listing“after being found to be safe,effective,and quality assured”.The easy storage requirements of CoronaVac make it very suitable for low resource settings.Since then,two inactivated vaccines developed by China National Biotec Group and Sinovac have been officially included in the WHO Emergency Use Listing.
